CN Patent

CN118307645A — 多肽的制备及其应用

Assigned to Guangdong Raynovent Biotech Co Ltd · Expires 2024-07-09 · 2y expired

What this patent protects

一系列多肽的制备及其应用，具体公开了式(II)所示序列的多肽。

USPTO Abstract

一系列多肽的制备及其应用，具体公开了式(II)所示序列的多肽。

Drugs covered by this patent

Patent Metadata

Patent number
CN118307645A
Jurisdiction
CN
Classification
—
Expires
2024-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Guangdong Raynovent Biotech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.